Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia Final evaluation


     Related Videos
Predicting Pharmacological Efficacy and Safety Profiles of Drugs using AurPASS
Conflict Decision Making and Self-Efficacy Following a Risk-Reduction Health Promotion
EU Military compared to US military and others

     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      Views: (1040)   Date: (13-03-09)   Pages: ()
    • Author:  Cartel JL  Spiegel A  Nguyen Ngnoc L  Cardines R  Plichart R  Martin PM  Roux JF  Moulia-Pelat JP.  

    • Abstract:  Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation. Cartel JL, Spiegel A, Nguyen Ngnoc L, Cardines R, Plichart R, Martin PM, Roux JF, Moulia-Pelat JP. Institut Territorial de Recherches Medicales Louis Malarde, Papeete, Tahiti, Polynesie Francaise. In October 1989, 58 apparently healthy Polynesian Wuchereria bancrofti carriers, in whom microfilarial (mf) density was greater than or equal to 100 mf/ml, were randomly allocated to treatment groups receiving single doses of either ivermectin at 100 mcg/kg or diethylcarbamazine (DEC) at 3 and 6 mg/kg. Six months later, half of the carriers initially treated with ivermectin 100 mcg/kg or DEC 3 mg/kg were given a second similar dose while the rest were given a placebo. Six months later again, all of the carriers received a last treatment dose similar to the initial one. The results observed during the 12-month period which followed this last treatment have confirmed that (i) in terms of immediate clearance or complete negativation of microfilaremia, the efficacy of ivermectin is higher than that of DEC (at dosage of 3 or 6 mg/kg), (ii) DEC is more effective than ivermectin in sustaining the reduction of microfilaremia over a longer period of time and (iii) the efficacy of repeated single doses of either DEC 3 mg/kg or ivermectin 100 mcg/kg is much higher when given semi-annually than annually.(ABSTRACT TRUNCATED AT 250 WORDS) PMID: 1519031 [PubMed - indexed for MEDLINE]

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

               Answers

               News
          • Spain confirms a recession in the making
            Spain's fourth quarter real gross domestic product (GDP) fell 0.3% quarter-on-quarter compared to the flat growth seen in the third quarter, according to the latest data from the country's official statistics ...
          • Highwoods Beats by a Penny
            Highwoods Properties Inc reported FFO (fund from operations) of $53.2 million or 70 cents per share in the fourth quarter of 2011 compared with $46.8 million or 62 cents per share in the year-earlier quarter....
          • Minnesota's per capita personal income compared to its neighbors
            How is Minnesota doing compared to other states? Are we falling behind? Staying ahead? People ask these questions whenever I give a public talk. Those questions lie behind much of the policy discussion going on in St. Paul about the governor's job plan, right-to-work laws and tax policy. Over the next few weeks, I'll take you on a guided tour of some data that sheds light on how well Minnesota ...
          • North-south pregnant smoking gap
            More women in the north of England smoke while pregnant compared with the south, official figures show.
          • Highlights of Stadshypotek's Annual Report
            January-December 2011 FINANCIAL PERFORMANCEFull year 2011 compared with full year 2010 Operating profits in 2011 rose by SEK 586 million to SEK 5,994 million (5,408). Net interest income amounted to SEK ...
          • Europe's GDP slides in fourth quarter
            BRUSSELS, Feb. 15 (UPI) -- The eurozone's economy grew in the fourth quarter compared to a year earlier, but shrank compared to the third quarter, Eurostat reported Wednesday.
          • Statkraft AS - results for the fourth quarter of 2011:
            Lower prices and write-downs  (Oslo, 16 February 2012) In the fourth quarter of 2011, Statkraft achieved an underlying 1 operating profit before depreciation (EBITDA) of NOK 3028 million, compared with ...
          • HCP Marginally Misses 4Q Estimates
            HCP reported fourth quarter 2011 FFO of $150.6 million or 37 cents per share, compared with $202.6 million or 62 cents in the year-earlier quarter.
          • Merge's EPS Beats, Revs Miss
            Merge reported adjusted EPS of 4 cents in the fourth quarter of fiscal 2011, which remained flat year over year but surpassed the Zacks Consensus Estimate of one cent.
          • MEAP scores show slight math, reading gains, but only compared to 'retro' scored exams
            Educators last year were accused of “lying to parents” about academic progress because students on some MEAP exams were allowed to answer as little as 39 percent of questions correctly and still be deemed “proficient.”

               Related on Wikipedia




























             

            Powered free by PHPmotion